Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia

Experimental Biology and Medicine

Volumn 233, Issue 5, 2008, Pages 558-574

  Bukowska, Alicja ^a   Schild, Lorenz ^a   Keilhoff, Gerburg ^a   Hirte, Daniel ^a   Neumann, Manfred ^a   Gardemann, Andreas ^a   Neumann, Klaus Hinrich ^a   Röhl, Friedrich Wilhelm ^a   Huth, Christof ^a   Goette, Andreas ^a   Lendeckel, Uwe ^a,b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

Arrhythmia; Ca channel; Mitochondria; Redox signalling

Indexed keywords

APOCYNIN; CALCIUM; CALCIUM CHANNEL L TYPE; CELL ADHESION MOLECULE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; OLMESARTAN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; RESVERATROL; VERAPAMIL;

AGED; ARTICLE; CALCIUM CURRENT; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; GENE EXPRESSION; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MALE; MITOCHONDRIAL RESPIRATION; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SUPRAVENTRICULAR TACHYCARDIA;

AGED; ATRIAL FUNCTION; CELL RESPIRATION; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION; HEME OXYGENASE-1; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MICROSCOPY, ELECTRON; MITOCHONDRIAL DISEASES; NF-KAPPA B; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; SCAVENGER RECEPTORS, CLASS E; SIGNAL TRANSDUCTION; TACHYCARDIA;

EID: 43249089348     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0706-RM-155     Document Type: Article

References (61)

1. Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing: structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 91:1588-1595, 1995.
2. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation: time course and mechanisms. Circulation 94:2968-2974, 1996.
3. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 415:219-226, 2002.
4. Ausma J, Dispersyn GD, Duimel H, Thone F, Ver Donck L, Allessie MA, Borgers M. Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation. J Mol Cell Cardiol 32:355-364, 2000.
5. Ausma J, Wijffels M, Thone F, Wouters L, Allessie M, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 96:3157-3163, 1997.
6. Spinale FG, Tomita M, Zellner JL, Cook JC, Crawford FA, Ziele MR. Collagen remodeling and changes in LV function during development and recovery from supraventricular tachycardia. Am J Physiol 261:H308-H318, 1991.
7. Kajstura J, Zhang X, Liu Y, Szoke E, Cheng W, Olivetti G, Hintze TH, Anversa P. The cellular basis of pacing-induced dilated cardiomyopathy: myocyte cell loss and myocyte cellular reactive hypertrophy. Circulation 92:2306-2317, 1995.
8. Cesselli D, Jakoniuk I, Barlucchi L, Beltrami AP, Hintze TH, Nadal-Ginard B, Kajstura J, Leri A, Anversa P. Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res 89:279-286, 2001.
9. Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 115:135-143, 2007.
10. Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, Bauer JA. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104:174-180, 2001.
11. Carnes CA, Chung MK, Nakayama T, Nakayama N, Baliga RS, Piao S, Kanderian A, Pavia S, Hamlin RL, McCarthy PM, Bauer JA, Van Wagoner DR. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 89:e32-e38, 2001.
12. Dhalla NS, Temsah RM, Netticadam D. Sarcoplasmic reticulum and cardiac oxidative stress: an emerging target for heart disease. Expert Opin Ther Targets 5:205-217, 2001.
13. Dhalla NS, Temsah RM, Netticadam D. Role of oxidative stress in cardiovascular diseases. J Hyperten 18:655-673, 2000.
14. Loh SH, Jin JS, Tsai CS, Chao CM, Tsai Y, Chen WH, Cheng TH, Chuang CC, Lin CI. Possible underlying mechanism for hydrogen peroxide-induced electromechanical suppression in human atrial myocardium. J Pharmacol Sci 91:53-60, 2003.
15. Ben Abraham R, Matza M, Marmor S, Rudick V, Frolkis I, Shapira I, Weinbroum AA. Electromechanical impairment of human auricle and rat myocardial strip subjected to exogenous oxidative stress. Eur J Cardiothorac Surg 23:66-73, 2003.
16. Kim YH, Lee JH, Lim DS, Shim WJ, Ro YM, Park GH, Becker KG, Cho-Chung YS, Kim MK. Gene expression profiling of oxidative stress on atrial fibrillation in humans. Exp Mol Med 35:336-349, 2003.
17. Lin PH, Lee SH, Su CP, Wei YH. Oxidative damage to mitochondrial DNA in atrial muscle of patients with atrial fibrillation. Free Radic Biol Med 35:1310-1318, 2003.
18. Dudley SC Jr, Hoch NE, McCann LA, Honeycutt C, Diamandopoulos L, Fukai T, Harrison DG, Dikalov SI, Langberg J. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation. 112:1266-1273, 2005.
19. Kim YM, Guzik TJ, Zhang YH, Zhang MH, Kattach H, Ratnatunga C, Pillai R, Channon KM, Casdei B. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res 97:629-636, 2005.
20. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86:494-501, 2000.
21. Keany JF. Oxidative stress and the vascular wall: NADPH oxidases take center stage. Circulation 112:2585-2588, 2005.
22. Goette A, Staack T, Röcken C, Arndt M, Geller C, Huth C, Ansorge S, Klein HU, Lendeckel U. Increased expression of extracellular-signal regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 35:1669-1677, 2000.
23. Goette A, Arndt M, Röcken C, Spiess A, Staack T, Geller JC, Huth C, Ansorge S, Klein HU, Lendeckel U. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation 101:2678-2681, 2000.
24. Schild L, Bukowska A, Gardemann A, Polczyk P, Keilhoff G, Täger M, Dudley SC, Klein HU, Goette A, Lendeckel U. Rapid pacing of embryoid bodies impairs mitochondrial ATP synthesis by a calcium-dependent mechanism - a model of in vitro differentiated cardiomyocytes to study molecular effects of tachycardia. Biochim Biophys Acta 1762:608-615, 2006.
25. Lendeckel U, Müller C, Röcken C, Laube B, Täger M, Huth C, Klein HU, Goette A. Expression of opioid receptor subtypes and their ligands in fibrillating human atria. PACE 28 (Suppl 1):S1-S5, 2005.
26. Goette A, Erxleben M, Bukowska A, Klein HU, Huth C, Lendeckel U, Röcken C. Angiotensin II receptor blockade reduces tachycardia-induced adhesion molecule expression in fibrillating atria (abstract). Heart Rhythm 2007.
27. Hammwöhner M, Ittenson A, Dierkes J, Bukowska A, Klein HU, Lendeckel U, Goette A. Platelet expression of CD40/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation. Exp Biol Med 232:581-589, 2007.
28. Bukowska A, Lendeckel U, Hirte D, Wolke C, Striggow F, Röhnert P, Huth C, Klein HU, Goette A. Activation of the calcineurin signaling pathway induces atrial hypertrophy during atrial fibrillation. Cell Mol Life Sci 63:333-342, 2006.
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987.
30. Drynda A, Quax PHA, Neumann M, van der Laan WH, Pap G, Drynda S, Meinecke I, Kekow J, Neumann W, Huizinga TWJ, Naumann M, König W, Pap T. Gene transfer of tissue inhibitor of metalloproteinases-3 reverses the inhibitory effects of TNF-α on Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts. J Immunol 174:6524-6531, 2005.
31. Magi B, Ettorre A, Liberatori S, Bini L, Andreassi M, Frosali S, Neri P, Pallini V, Di Stefano A. Selectivity of protein carbonylation in the apoptotic response to oxidative stress associated with photodynamic therapy: a cell biochemical and proteomic investigation. Cell Death Differ 11:842-852, 2004.
32. Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 29:222-230, 2000.
33. Collins TJ, Lipp P, Berridge MJ, Bootman MD. Mitochondrial Ca(2+) uptake depends on the spatial and temporal profile of cytosolic Ca(2+) signals. J Biol Chem 276:26411-26420, 2001.
34. Halestrap AP. Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Trans 34:232-237, 2006.
35. Ravens U, Liu GS, Vandeplassche G, Borgers M. Protection of human, rat and guinea-pig atrial muscle by mioflazine, lidoflazine, and verapamil against the destructive effects of high concentrations of Ca2+. Cardiovasc Drugs Ther 6:47-58, 1992.
36. Akar JG, Everett TH, Ho R, Craft J, Haines DE, Somlyo AP, Somlyo AV. Intracellular chloride accumulation and subcellular elemental distribution during atrial fibrillation. Circulation 107:1810-1815, 2003.
37. Kawahara K, Takase M, Yamauchi Y. Ruthenium red-induced transition from ventricular fibrillation to tachycardia in isolated rat hearts: possible involvement of changes in mitochondrial calcium uptake. Cardiovasc Pathol 12:311-321, 2003.
38. Mason RP, Mak IT, Walter MF, Tulenko TN, Mason PE. Antioxidant and cytoprotective activities of the calcium channel blocker mibefradil. Biochem Pharmacol 55:1843-1852, 1998.
39. Dolmetsch RE, Xu K, Lewis RS. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 392:933-936, 1998.
40. Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 85:753-766, 1999.
41. Lin CC, Chiang LL, Lin CH, Shih CH, Liao YT, Hsu MJ, Chen BC. Transforming growth factor-beta1 stimulates heme oxygenase-1 expression via the PI3K/Akt and NF-kappaB pathways in human lung epithelial cells. Eur J Pharmacol 560:101-109, 2007.
42. Tyrell R. Redox regulation and oxidant activation of heme oxygenase-1. Free Radic Res 31:335-340, 1999.
43. Ishii T, Itoh K, Takahashi S, Sato H, Yanagawa T, Katoh Y, Bannai S, Yamamoto M. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 275:16023-16029, 2000.
44. Nagase M, Abe J, Takahashi K, Ando J, Hirose S, Fujita T. Genomic organization and regulation of expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) gene. J Biol Chem 273:33702-33707, 1998.
45. Chen J, Liu Y, Liu H, Hermonat PL, Mehta JL. Molecular dissection of angiotensin II-activated human LOX-1 promoter. Arterioscler Thromb Vasc Biol 26:1163-1168, 2006.
46. Nagase M, Ando K, Nagase T, Kaname S, Sawamura T, Fujita T. Redox-sensitive regulation of lox-1 gene expression in vascular endothelium. Biochem Biophys Res Commun 281:720-725, 2001.
47. Murase T, Kume N, Korenaga R, Ando J, Sawamura T, Masaki T, Kita T. Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res 83:328-333, 1998.
48. Minami M, Kume N, Kataoka H, Morimoto M, Hayashida K, Sawamura T, Masaki T, Kita T. Transforming growth factor-beta(1) increases the expression of lectin-like oxidized low-density lipoprotein receptor-1. Biochem Biophys Res Commun 272:357-361, 2000.
49. Kume N, Murase T, Moriwaki H, Aoyama T, Sawamura T, Masaki T, Kita T. Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res 83:322-327, 1998.
50. Li DY, Zhang YC, Philips MI, Sawamura T, Mehta JL. Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation. Circ Res 84:1043-1049, 1999.
51. Cominacini L, Pasini AF, Garbin U, Davoli A, Tosetti ML, Campagnola M, Pastorino AM, Lo Cascio V, Sawamura T. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem 275:12633-12638, 2000.
52. Goette A, Bukowska A, Lendeckel U, Erxleben M, Hammwöhner M, Strugala D, Pfeiffenberger J, Röhl F-W, Huth C, Ebert MPA, Klein HU, Röcken C. Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression. Circulation 117:732-742, 2008.
53. Sakurai K, Sawamura T. Stress and vascular responses: endothelial dysfunction via lectin-like oxidized low-density lipoprotein receptor-1: close relationships with oxidative stress. J Pharmacol Sci 91:182-186, 2003.
54. Banning A, Brigelius-Flohe R. NF-kappaB, Nrf2, and HO-1 interplay in redox-regulated VCAM-1 expression. Antioxid Redox Signal 7:889-899, 2005.
55. Scapagnini G, Foresti R, Calabrese V, Giuffrida Stella AM, Green CJ, Motterlini R. Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Mol Pharmacol 3:554-561, 2002.
56. Stahnke T, Stadelmann C, Netzler A, Brück W, Richter-Landsberg C. Differential upregulation of heme oxygenase-1 (HSP32) in glial cells after oxidative stress and in demyelinating disorders. J Mol Neurosci 32:25-37, 2007.
57. Das S, Fraga CG, Das DK. Cardioprotective effect of resveratrol via HO-1 expression involves p38 map kinase and PI-3-kinase signaling, but does not involve NFkappaB. Free Radic Res 40:1066-1075, 2006.
58. Rivard L, Sinno H, Shiroshita-Takeshita A, Schram G, Leung TK, Nattel S. The pharmacological response of ischemia-related atrial fibrillation in dogs: evidence for substrate-specific efficacy. Cardiovasc Res 74:104-113, 2007.
59. Amar D, Poistacher N, Rusch VW, Leung DH, Ginsburg I, Zhang H, Bains MS, Downey RJ, Korst RJ, Ginsberg RJ. Effects of diltiazem prophylaxis on the incidence and clinical outcome of atrial arrhythmias after thoracic surgery. J Thorac Cardiovasc Surg 120:790-798, 2000.
60. Lamirault G, Gaborit N, Le Meur N, Chevalier C, Lande G, Demolombe S, Escande D, Nattel S, Leger JJ, Steenman M. Gene expression profile associated with chronic atrial fibrillation and underlying valvular heart disease in man. J Mol Cell Cardiol 40:173-184, 2006.
61. Gaborit N, Steenman M, Lamirault G, Le Meur N, Le Bouter S, Lande G, Leger J, Charpentier F, Christ T, Dobrev D, Escande D, Nattel S, Demolombe S. Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation. Circulation 112:471-481, 2005.